Category: Latest
5-hour ENERGY drink makers fined $4.3 million (£3.2 million) for “false” advertising
A popular energy drink company has been fined around £3.2 million after they were found to have produced “false” advertising.
Living Essentials LLC, a company who manufactures a drink product called “5-hour ENERGY”, marketed themselves as the world’s number one selling energy shot where it provides the “bright, alert feeling you need to get through your day without making you feel wired up”.
Their website states that it’s still number one in the U.S. “by a wide margin – because it works”.
read more
Lloyds bank set to pay out £1 billion for customer charges
Leading U.K. bank, Lloyds Banking Group, has pledged to refund all fees they charged to customers between 2009 and 2016.
After discussions with the FCA, Lloyds agreed to refund fees they charged to customers who fell behind on their mortgage payments between 1st January 2009 and January 2016. Reportedly, Lloyds charged fees for arrears management and broken payments without checking with customers that the repayment plans were affordable, which is said to be the reason for the refunds.
read more
Major drug manufacturers and distributors suspected of colluding to inflate profits at consumers’ expense
Several drug manufacturers, suppliers and pharmacy benefit managers have reportedly been caught colluding to fix prices for insulin.
In what’s believed to be efforts to allegedly inflate profits, companies reportedly worked together to set consistently high prices for the drugs. This way, no matter where consumers purchased their insulin from, they’d be paying high prices. By price-fixing, no company undercuts the other by offering a cheaper price, which is anti-competitive behaviour that can be extremely harmful for competition and for the consumer.
These are the accusations being brought by those bringing a legal action.
read more
Novo Nordisk agrees to settlement for questionable sales tactics
Danish multinational pharmaceutical giant Novo Nordisk is one of the leading global manufacturers of medical drugs.
They stand accused of using questionable tactics to drive up sales.
Novo Nordisk reportedly took their marketing a step further by disguising salespeople as medical professionals and educators. The Novo Nordisk employees would apparently pretend to be experts in medicine and recommend the company’s own drugs like professors advertising their own textbooks to students. The drug maker is also accused of paying kickbacks to doctors and medical staff to encourage them to prescribe the company’s own medicines.
read more
Student nurses at the University of Derby told of possible blood contamination receive financial compensation with Group Action Lawyers
Our lawyers successfully helped former student nurses recover financial compensation for the University of Derby’s negligent actions that put them at risk of infection through blood contamination.
The cases were settled outside of court by our expert team of lawyers.
As soon as news broke of the scandal, we were on the case and offering our services to anyone affected. A number of individuals approached us for help and advice, and we took forward claims on a No Win, No Fee basis for individuals affected.
read more
Who is to blame for Tesla car crash in Minnesota?
A 58-year-old driver of a Tesla car was involved in a car crash in Minnesota on the 17th July 2017. The high tech vehicle, produced by Elon Musk’s Tesla car company, is installed with ‘self-driving’ technology that’s designed to assist drivers in their journeys with automatic driving capabilities.
However, they’ve come under huge scrutiny after a number of incidents have led to crashes that have fuelled calls that the technology just isn’t ready yet; and certainly isn’t safe.
In this incident, police authorities reported that the driver had “engaged the self-driving mode” when it “suddenly accelerated, causing the car to leave the road and overturn”.
So, was this human error or technological error?
read more
Medtronic under greater scrutiny as more of its products run into problems
Medical device maker Medtronic have been making the headlines for all the wrong reasons lately. Priding itself as the “global leader in medical technology, services, and solutions”, Medtronic have been at the centre of a fair few recalls for defects and risks that have arisen from the use of their products.
In the latest issues, scrutiny has come from issues with their products and an alleged lack of warning for equipment incompatibility.
read more
Depression and chronic pain relief drug, Duloxetine, recalled after failing tests
The drug Duloxetine, more commonly known as its brand name Cymbalta, is generally used to treat depression, anxiety, and chronic pain. It’s an active ‘serotonin-norepinephrine reuptake inhibitor’, providing pain relief for patients with diabetes or sufferers from chronic or widespread pain.
The drug is commonly prescribed to people with arthritis and fibromyalgia. However, select batches of the Torrent Dutor Gastro-resistant Capsules have been recalled by the Medicines and Healthcare products Regulatory Agency (MHRA) because “out of specification results for dissolution were obtained during routine stability testing”.
read more
Takata files for bankruptcy as a result of exploding airbag scandal
The Takata airbag recall is one of the biggest automotive recalls in history. The company started producing airbag inflators in the late 1990s, and around the year 2000, Takata discovered some of their airbag inflators weren’t functioning properly, and even found some had erupted during tests.
The first recorded incident reportedly happened in May 2004 where a driver’s side bag ruptured in a Honda Accord. It was not until half a decade later that Honda recalled more than 500,000 airbags for the defect to be rectified, and regulators didn’t start investigations until June 2014.
Now, the scale of the issue has resulted in the Japanese manufacturer filing for bankruptcy.
read more
Medical device alert issued for Prismaflex Haemofiltration machines
A medical device alert has been issued warning hospitals and healthcare institutions that Prismaflex Haemofiltration machines are susceptible to software failure.
Machines manufactured by Baxter, and installed with the 6.10 version of software, may not compute information about syringe size and the brand of syringe used. As a result, the machine may revert back to default settings, which means it will work at the lowest possible plunger speed which may therefore lead to under-dosage.
When under-dosing occurs, a lack of anti-coagulants may be added to the blood. Without carefully measured anti-coagulants, the patient’s blood may then be at a high risk of clotting, which can of course lead to potentially serious consequences.
read more